This new pill to treat celiac disease comes from egg yolks
A study by researchers from the University of Alberta shows promise in a new treatment for celiac disease, one which uses an antibody derived from egg yolks to neutralize gluten’s impact on the digestive system.
Estimated to affect about one per cent of the population worldwide, celiac disease is described as an intolerance to ingested gluten, a protein found in wheat, rye and barley which for celiacs can result in the malabsorption of food nutrients. Gluten intolerance leads to a range of symptoms such as anemia, chronic diarrhea, fatigue, headaches, bloating, confusion and irritability.
So far, the main treatment option for celiacs has been a strict diet regimen involving the total avoidance of gluten. But even for those faithfully adhering to such a program, the complete avoidance of exposure to gluten remains a problem, say the study’s authors.